Alan Krupnick EPRI/RFF Webinar Series #4 December 16, 2014 Can the - - PowerPoint PPT Presentation

alan krupnick epri rff webinar series 4 december 16 2014
SMART_READER_LITE
LIVE PREVIEW

Alan Krupnick EPRI/RFF Webinar Series #4 December 16, 2014 Can the - - PowerPoint PPT Presentation

Ancillary Benefits from the Clean Power Plan Alan Krupnick EPRI/RFF Webinar Series #4 December 16, 2014 Can the CPP be justified from ancillary benefits alone? Ancillary benefits are side effects of a policy Conventional air quality


slide-1
SLIDE 1

Ancillary Benefits from the Clean Power Plan

Alan Krupnick

EPRI/RFF Webinar Series #4 December 16, 2014

slide-2
SLIDE 2

Can the CPP be justified from ancillary benefits alone?

  • Ancillary benefits are side effects of a policy 

Conventional air quality benefits of a climate policy

  • The USEPA estimates the costs and benefits of a proposed

policy in a Regulatory Impact Analysis, required by Executive Order

  • Ancillary benefits typically included
  • For the CPP (2025)
  • Costs = $5.5 B
  • Ancillary benefits >= Climate benefits
  • Climate benefits > Costs

YES!

slide-3
SLIDE 3
slide-4
SLIDE 4

Details/Critique of Ancillary Benefits

slide-5
SLIDE 5

Pollutants affected by CPP

  • PM2.5 precursors
  • Black carbon
  • Particulate organic matter (POM)
  • Sulfur dioxide (SO2)  KEY
  • Nitrogen oxides (NOx)
  • Ozone precursors
  • Nitrogen oxides (NOx)
  • Volatile Organic Carbons (VOCs)

Associated climate impacts of black carbon, SO2,

  • etc. not calculated in RIA
slide-6
SLIDE 6

Air quality modeling

  • Continental U.S. coverage
  • Base year for emissions and meteorology is 2005
  • Utility emissions estimates for 2016 are from IPM
  • Include reductions related to NOx SIP Call,

Transport Rule, MATS

  • Source apportionment from CMAQ and a study
  • No bottom up modeling of change in emissions
slide-7
SLIDE 7

Health effects

Most significant health benefit for both pollutants is mortality

  • 98% of PM monetized value, >90% of ozone value
  • Adult PM-related mortality: the American Cancer Society cohort (Krewski et

al., 2009) and the Harvard Six Cities cohort (Lepeule et al., 2012). Using relative risk estimates from both studies & expert elicitation study (Roman et al., 2008; IEc, 2006)

  • Co-benefits avoiding short-term ozone mortality: Bell et al. (2004) NMMAPS

analysis, the Schwartz (2005) multi-city study, the Huang et al. (2005) multi-city study , and 3 meta-analyses: Bell et al. (2005), Levy et al. (2005), and Ito et al. (2005)

slide-8
SLIDE 8

Economic benefits for health co-benefits

  • Premature deaths: value of a statistical life (VSL) approach
  • EPA working to update VSL guidance
  • Currently, uses single estimate: $8.2 million (2011$)
  • Discount future mortality 3% and 7%
  • Assumes “cessation” lag between exposures and health

effects

  • WTP estimates for changes in risk of a health effect
  • For some health effects, cost-of-illness estimates are used (generally

underestimate value)

  • Benefits are calculated at regional level (East, West, and

California

slide-9
SLIDE 9
slide-10
SLIDE 10

Other quantified effects

  • PM 2.5 (PM Integrated Science Assessment, 2009)
  • Non-fatal heart attacks
  • Hospital admissions
  • Asthma and respiratory systems
  • Lost work days
  • Minor restricted-activity days
  • Ozone (Ozone Integrated Science Assessment, 2013)
  • Hospital admissions – respiratory causes
  • Emergency department visits
  • Minor restricted-activity days
  • School absence days
slide-11
SLIDE 11

Economic benefits for PM2.5

EPA’s take on modelling issues

All estimates reflect geographic distribution of modeled emissions, which...

  • May not match reductions anticipated by guidelines
  • May not reflect local variability in population density, meteorology,

exposure, and baseline health incidence

  • Assumes linear atmospheric response to emission reductions (largely

accurate for SO2 but not NOx)

slide-12
SLIDE 12

Economic benefits for Ozone

EPA’s take on modelling issues

All estimate reflect geographic distribution of modeled emission, which are similar to those of PM 2.5 except …

  • Are equal to the sum of premature mortality and morbidity of reducing NOx

Not VOC

  • Based on NOx emissions during the ozone season (May - September), which

is an underestimate in areas with longer ozone season

  • NOx contribution to ozone is non-linear, and thus using average benefit-per-

ton estimate adds uncertainty

slide-13
SLIDE 13

Other issues

  • What’s in the baseline?
  • MATS; Transport Rule, etc.
  • Not: New Ozone Regs, PHASE I and II, 2012 CAFÉ
  • What’s being assumed for the policies?
  • Ancillary benefits are sensitive to form and stringency
slide-14
SLIDE 14

Ancillary benefits depend on structure of the regulation

  • Final structure depends on state compliance plans!

2020

(2010$)

Carbon Tax National Emissions Rate Standard Cap and Trade with Allowance Value to LDCs

Fossil Emissions Rate

(lbs/MWh)

1,417 1,332 1,349

Total Welfare Change: Cost

(B$)

  • 3
  • 7
  • 7

Total Welfare Change: CO2 Benefits (B$)

16 16 16

Total Welfare Change: SO2 Benefits (B$)

17 22 21 Equal (400 mty) CO2 reduction across scenarios: three policies

Burtraw, Linn, Palmer, Paul 2014; AER P&P

slide-15
SLIDE 15

Other issues ctd.

  • What’s in the baseline?

– New Ozone Regs, PHASE I and II, 2012 CAFÉ

  • What’s being assumed for the policies?

– Ancillary benefits are sensitive to form and stringency

  • Are there thresholds in health effects? Where?
  • Implication of NAAQS
  • Mortality C-Rs
  • VSL

 Fraas and Lutter: factor of 10 lower AB

  • No confidence intervals, only CR mortality model

uncertainty

slide-16
SLIDE 16

Other issues ctd.

Does not include:

  • Health effects from direct exposure to NOx and Sox
  • Ecosystem effects
  • Visibility impairment
slide-17
SLIDE 17

Conclusions

  • Ancillary benefits are legitimate and appropriate for the RIA
  • Further benefit of legitimizing making ancillary benefits

primary and CO2 benefits ancillary

  • Some issues lead to underestimates of AB
  • Some lead to overestimates
  • Lots of overarching uncertainty – statistical uncertainty not

addressed; model uncertainties very limited